Anti-Aspergillus Prophylaxis in Lung Transplantation: A Systematic Review and Meta-analysis (Q38156666)

29 August 2017

Anti-Aspergillus Prophylaxis in Lung Transplantation: A Systematic Review and Meta-analysis (English)

1 reference

29 August 2017

1 reference

1 reference

1 reference

Archana Bhaskaran

1

1 reference

PubMed ID

24173585

29 August 2017

Khalid Mumtaz

series ordinal

2

1 reference

PubMed ID

24173585

29 August 2017

Shahid Husain

series ordinal

3

1 reference

29 August 2017

1 December 2013

1 reference

Current infectious disease reports

29 August 2017

1 reference

29 August 2017

15

1 reference

29 August 2017

6

1 reference

29 August 2017

514-525

1 reference

Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET).

29 August 2017

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0380-Y

Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0380-Y

Aspergillus infection in lung transplant recipients with cystic fibrosis: risk factors and outcomes comparison to other types of transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0380-Y

An unwelcome guest: Aspergillus colonization in lung transplantation and its association with bronchiolitis obliterans syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0380-Y

Aspergillus colonization of the lung allograft is a risk factor for bronchiolitis obliterans syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0380-Y

A survey of anti-fungal management in lung transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0380-Y

Variation in antifungal prophylaxis strategies in lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0380-Y

Aspergillosis in solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0380-Y

Meta-Analyst: software for meta-analysis of binary, continuous and diagnostic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0380-Y

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0380-Y

Invasive fungal infections in lung transplant recipients not receiving routine systemic antifungal prophylaxis: 12-year experience at a university lung transplant center.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0380-Y

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0380-Y

A 2010 working formulation for the standardization of definitions of infections in cardiothoracic transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0380-Y

Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0380-Y

The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxis in lung transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0380-Y

Use of prophylactic voriconazole for three months after lung transplantation does not reduce infection with Aspergillus: a retrospective study of 147 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0380-Y

Safety of aerosolized liposomal versus deoxycholate amphotericin B formulations for prevention of invasive fungal infections following lung transplantation: a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0380-Y

Feasibility, tolerability, and outcomes of nebulized liposomal amphotericin B for Aspergillus infection prevention in lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0380-Y

Antifungal prophylaxis with voriconazole or itraconazole in lung transplant recipients: hepatotoxicity and effectiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0380-Y

Risk factors for voriconazole hepatotoxicity at 12 weeks in lung transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0380-Y

Nebulized liposomal amphotericin B prophylaxis for Aspergillus infection in lung transplantation: pharmacokinetics and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0380-Y

Intrapulmonary disposition of amphotericin B after aerosolized delivery of amphotericin B lipid complex (Abelcet; ABLC) in lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0380-Y

Nebulized amphotericin B prophylaxis for Aspergillus infection in lung transplantation: study of risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0380-Y

Safety of aerosolized amphotericin B lipid complex in lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0380-Y

Itraconazole prophylaxis in lung transplant recipients receiving tacrolimus (FK 506): efficacy and drug interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0380-Y

Efficiency and safety of inhaled amphotericin B lipid complex (Abelcet) in the prophylaxis of invasive fungal infections following lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0380-Y

Control of early Aspergillus mortality after lung transplantation: outcome and risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0380-Y

Prospective, observational study of voriconazole therapeutic drug monitoring among lung transplant recipients receiving prophylaxis: factors impacting levels of and associations between serum troughs, efficacy, and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0380-Y

Preemptive treatment with voriconazole in lung transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0380-Y

A Targeted Peritransplant Antifungal Strategy for the Prevention of Invasive Fungal Disease After Lung Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0380-Y

Antifungal Prophylaxis in Lung Transplantation-A World-wide Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0380-Y

Voriconazole Prophylaxis in Lung Transplant Recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0380-Y

Significant reduction in the number of fungal infections after lung-, heart-lung, and heart transplantation using aerosolized amphotericin B prophylaxis

21 January 2018

1 reference

12 December 2020

Pre-emptive therapy with azoles in lung transplant patients

1 reference

12 December 2020

Antifungal prophylaxis during the early postoperative period of lung transplantation. Valencia Lung Transplant Group

1 reference

12 December 2020

Aspergillus airway colonization and invasive disease after lung transplantation

1 reference

12 December 2020

Surveillance of invasive mold infections in lung transplant recipients: effect of antimycotic prophylaxis with itraconazole and voriconazole

1 reference

12 December 2020

Fungal infection in heart-lung transplant recipients receiving single-agent prophylaxis with itraconazole.

1 reference

12 December 2020

10.1007/S11908-013-0380-Y

Identifiers

DOI

1 reference

29 August 2017

1 reference

PubMed ID

24173585